Simdax, 2,5 mg/mL, koncentrat do sporządzania roztworu do infuzji, GLUCOSUM 5% FRESENIUS, 50 mg/ml, roztwór do infuzji clinical trials

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Levosimendan Therapy in low ejection fraction Takotsubo Syndrome (LevoTako Trial)

The LevoTako trial looks at a medicine called Levosimendan for people with a temporary heart condition called Takotsubo Syndrome. It's a large study to see if this medicine helps the heart recover faster while in the hospital.